Search Results - ke+shuai

1 Results

Sort By:

Targeting the SV2 Family of Proteins for Immune Regulation (UCLA Case No. 2021-122)

UCLA researchers in the Department of Medicine have identified the SV2 family of proteins as novel druggable targets for suppressing severe inflammation, including COVID-19 pneumonia. Background: In critical COVID-19, the infection causes severe inflammation and excess fluid in the lungs, leading to breathing difficulties (COVID-19 pneumonia). Recent...

Published: 8/13/2025 | Inventor(s): Ke Shuai

Keywords(s):

Category(s): Therapeutics > Inflammation And Inflammatory Diseases, Therapeutics > Respiratory And Pulmonary